Key result
Novel EAT-CAC model linked to ~3-fold higher major cardiovascular events risk, improving discrimination over CAC alone.
Why the study?
CT calcium scoring has lower discrimination in females, and it was hypothesized that epicardial adipose tissue fat-omics could provide incremental prognostic information and improve female MACE prediction.
Does integrating epicardial 'fat-omics' with CAC score improve MACE prediction in individuals without known ASCVD?
Cohort (n=40,851)
No
Does integrating epicardial 'fat-omics' with CAC score improve MACE prediction in individuals without known ASCVD?
Integrating epicardial fat-omics into standard CT calcium scoring significantly enhances risk stratification, especially in females and individuals with zero or low CAC, advancing personalized cardiovascular prevention.
Answers are grounded in this paper and cite their sources.
Supports adding EAT features to CAC scoring for better female MACE prediction; hypothesis-generating pending prospective validation.
Background: The Agatston CAC score from CT-calcium scoring (CTCS) is a standard guideline recommended measure for cardiovascular risk assessment that quantifies calcified plaque burden. However, many studies have reported lower discrimination of CTCS in females. Embedded epicardial adipose tissue (EAT) features have previously been shown to improve prediction of calcium scoring, and we hypothesized that it may provide incremental prognostic information in females. In this study, we evaluate whether integrating epicardial "fat-omics" with CAC score improves major adverse cardiac events (MACE) prediction from CTCS in females and assess the added value of sex-specific modeling. Methods: 40,851 individuals undergoing CTCS for primary prevention (CLARIFY Registry, NCT04075162) were analyzed. MACE was defined as myocardial infarction, stroke, revascularization, or mortality. A validated deep learning model segmented EAT, and 211 "fat-omics" features were extracted. Cox models were trained using CAC score, CAC with fat-omics (EAT-CAC), and sex-specific EAT-CAC models trained. Performance was evaluated on a held-out test set (20 %) using C-index, calibration, and decision curves. CAC). No significant changes were observed in males. EAT-CAC models demonstrated good calibration, improved net benefit, and remained independently predictive after comorbidity adjustment (HR = 2.96, p < 0.001). Conclusions: Sex-specific risk models incorporating epicardial fat-omics from CTCS improve risk prediction in females and equity in cardiovascular risk assessment.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2025) conducted a cohort in Primary prevention without known ASCVD (n=40,851). Epicardial fat-omics integrated with CAC score (EAT-CAC) vs. CAC score alone was evaluated on MACE (myocardial infarction, stroke, revascularization, or mortality) (HR 2.96, 95% CI 2.08-4.20, p=<0.001). The EAT-CAC model integrating epicardial fat-omics remained an independent predictor of major adverse cardiac events and improved risk discrimination, especially in females.
Synapse has enriched 10 related papers. Consider them for comparative context: